Occludine, une clé de plus pour l’entrée du virus de l’hépatite C

Birke Andrea Tews; Laurence Cocquerel

doi:10.1051/medsci/2009256-7549

Accueil

Tous les numéros

Volume 25 / Numéro 6-7 (Juin-Juillet 2009)

Med Sci (Paris), 25 6-7 (2009) 549-551

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 25, Numéro 6-7, Juin-Juillet 2009


Page(s)		549 - 551
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/2009256-7549
Publié en ligne		15 juin 2009

Lemon SM, Walker C, Alter MJ, et al. Hepatitis C virus. In : Knipe DM, Howley PM, eds. Fields virology, vol. 1, 5^th ed. Philadelphia : Lippincott-Williams and Wilkins, 2007 : 1253–304. [Google Scholar]
Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998; 282 : 938–41. [Google Scholar]
Scarselli E, Ansuini H, Cerino R, et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 2002; 21 : 5017–25. [Google Scholar]
Evans MJ, von Hahn T, Tscherne DM, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007; 446 : 801–5. [Google Scholar]
Dubuisson J, Helle F, Cocquerel L. Early steps of the hepatitis C virus life cycle. Cell Microbiol 2008; 10 : 821–7. [Google Scholar]
Liu S, Yang W, Shen L, et al. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 2009; 83 : 2011–4. [Google Scholar]
Ploss A, Evans MJ, Gaysinskaya VA, et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009; 457 : 882–6. [Google Scholar]
Benedicto I, Molina-Jimenez F, Barreiro O, et al. Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum. Hepatology 2008; 48 : 1044–53. [Google Scholar]
Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 2006; 124 : 119–31. [Google Scholar]
Coyne CB, Shen L, Turner JR, et al. Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2007; 2 : 181–92. [Google Scholar]
Enel C, Minello A, Jooste V, et al. Dans l’hépatite chronique C, les délais entre diagnostic et traitement sont liés à la relation médecins-patients. Med Sci (Paris) 2009; 25 : 519–23. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Lemon SM, Walker C, Alter MJ, et al. Hepatitis C virus. In : Knipe DM, Howley PM, eds. Fields virology, vol. 1, 5^th ed. Philadelphia : Lippincott-Williams and Wilkins, 2007 : 1253–304. [Google Scholar]

[2] Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998; 282 : 938–41. [Google Scholar]

[3] Scarselli E, Ansuini H, Cerino R, et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 2002; 21 : 5017–25. [Google Scholar]

[4] Evans MJ, von Hahn T, Tscherne DM, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007; 446 : 801–5. [Google Scholar]

[5] Dubuisson J, Helle F, Cocquerel L. Early steps of the hepatitis C virus life cycle. Cell Microbiol 2008; 10 : 821–7. [Google Scholar]

[6] Liu S, Yang W, Shen L, et al. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 2009; 83 : 2011–4. [Google Scholar]

[7] Ploss A, Evans MJ, Gaysinskaya VA, et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009; 457 : 882–6. [Google Scholar]

[8] Benedicto I, Molina-Jimenez F, Barreiro O, et al. Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum. Hepatology 2008; 48 : 1044–53. [Google Scholar]

[9] Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 2006; 124 : 119–31. [Google Scholar]

[10] Coyne CB, Shen L, Turner JR, et al. Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe 2007; 2 : 181–92. [Google Scholar]

[11] Enel C, Minello A, Jooste V, et al. Dans l’hépatite chronique C, les délais entre diagnostic et traitement sont liés à la relation médecins-patients. Med Sci (Paris) 2009; 25 : 519–23. [Google Scholar]